Our leaders work collaboratively to apply next generation disease prevention and management approaches, supportive and enabling technologies, and related advances in chronic disease.
CDIC is led by a core group of principal investigators with a broad array of medical, data analytics, health economics and research skills under one roof. This expertise combined with benefits of being situated within a community hospital with access to the Wellness Institute, and a market-oriented posture, combine to present a compelling case for commercial partners.
Dr. Paul Komenda, Research Director, is an Associate Professor of Medicine in the Section of Nephrology at the University of Manitoba where he has been on faculty since 2007. He has completed a Masters in Health Administration at the Sauder School of Business in addition to a research fellowship at the University of British Columbia.
Dr. Komenda has over 140 published peer reviewed articles in health services research and clinical nephrology since 2008. He has obtained provincial and national level grants in excess of 4 million dollars and completed the EXTRA (Executive Training for Research Applications) program funded by the Canadian Health Services Research Foundation.
He serves as Research Director at the Chronic Disease Innovation Centre @SOGH and is currently the Chief Medical Officer of Quanta Dialysis Technologies.
Dr. Rebecca Mollard is a Clinical Research Associate at the Chronic Disease Innovation Centre and an Adjunct Professor in The Department of Food and Human Nutritional Sciences at the University of Manitoba. She completed a PhD in Human Nutritional Sciences in 2005 and a Postdoctoral Fellowship in the Department of Nutritional Sciences at the University of Toronto in 2011. Over the past decade, Dr. Mollard has conducted and published multiple acute and long-term clinical trials investigating the acute and long-term effects of foods and food components on satiety, glycaemia and cardiometabolic outcomes. Her current areas of research interest include nutrition, diabetes, obesity, clinically managed weight loss and chronic kidney disease.
Dr. Claudio Rigatto, Academic Director, is an Associate Professor, University of Manitoba Faculty of Medicine and an attending Nephrologist at both St. Boniface and Seven Oaks General Hospitals. He received his medical training at the University of Manitoba, including a BSc. in Medicine, and at Memorial University in Newfoundland where he received his MSc. in Medicine.
He has been the recipient of numerous major research grants. He is currently one of the lead investigators for the Canadian Study of Prediction of Risk and Evolution to Dialysis, Death and Interim Cardiovascular Events Over Time.
Dr. Clara Bohm attained her medical degree at McMaster University and also received a Masters of Public Health at Johns Hopkins School of Public Health. She is an Assistant Professor in the Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba and a Research Affiliate with the Health, Leisure and Human Performance Institute, Faculty of Kinesiology and Recreation Management, University of Manitoba. Her research focuses on characterizing the effects of exercise and physical activity on functional status, quality of life and adverse outcomes in individuals with all stages of chronic kidney disease and translating these findings to design and implement sustainable evidence-based exercise programming to improve outcomes in this population. She was the Medical Lead of the Manitoba Renal Program Exercise and Wellness Program which was the first in Canada to formally incorporate exercise and physical activity programming into clinical care for individuals with CKD. She currently holds the Manitoba Medical Service Foundation Dr. F. W. Du Val Clinical Research Professorship (2019-2022).
Dr. Navdeep Tangri, Scientific Director, is an attending physician and Associate Professor in the Division of Nephrology, Department of Medicine and the Department of Community Health Sciences at the University of Manitoba. Dr Tangri’s research program is clinical and translational and focused on improving clinical decision making for patients with advanced chronic kidney disease. He developed and validated the Kidney Failure Risk Equation (KFRE) to predict the need for dialysis in patients with CKD, and is presently engaged in multiple validation and implementation exercises to increase the uptake of the KFRE.
Dr. Ricardo Lobato de Faria is the Medical Director for the Seven Oaks Emergency Department. As a Family Physician and Process Engineer Dr. De Faria tirelessly pursues process efficiency in Emergency Medicine and in the hospital. He was responsible for the innovative implementation of Patient Order Sets at Seven Oaks and is currently collaborating to create a computer model that captures all relevant ER activity for virtual testing of improvements.
Dr. Sean Armstrong is Medical Director of Hemodialysis at Seven Oaks General Hospital, Associate Professor of Medicine, University of Manitoba Rady Faculty of Health Sciences, Chair of the North American Peritoneal Dialysis University and Medical Director, Interventional Nephrologists. Dr. Armstrong is a leader in training physicians in bedside catheter insertion globally, a technique that has dramatically improved access to Peritoneal Dialysis and helped alleviate painful fluid buildup for certain cancer and other patients.